相关实验视频

Updated: Sep 11, 2025

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols

Published on: January 2, 2013

在输血前测试中,抗CD47药物干扰可以通过抗原掩饰来克服

Cora P Habicht¹, Svenja Adolph¹, Daniela Grüger¹

¹imusyn GmbH & Co. KG, Hanover, Germany.

|August 13, 2025

概括

新的抗CD47疗法可以干扰输血. 一种新的抗原掩蔽策略有效地减轻了这种干扰,确保了接受这些新药治疗的患者更安全地使用血液产品.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

CD47的过度表达,一个"不要吃我"的信号,驱动着对恶性瘤的抗CD47治疗的发展.
尽管有挫折,比如马格罗利马布的试验中止,但几种抗CD47药物正在临床试验中.
红细胞上的CD47会导致凝结,干扰输血前的诊断.

研究的目的:

在输血前的测试中评估新的抗CD47抗体 (ligufalimab,lemzoparlimab,letaplimab) 和SIRPα融合蛋白的干扰.
为了将干扰效应与magrolimab进行比较.
为了测试抗原掩蔽以减轻抗CD47药物干扰.

主要方法:

测试抗CD47抗体和SIRPα融合蛋白用于输血前测试干扰.
将干扰与magrolimab进行比较.
评估使用可溶性复合SIRPα变体 (MagroEx) 的抗原掩护疗效.

主要成果:

所有测试的抗CD47药物都在临床度下对输血前测定产生了显著干扰.
干扰影响了间接抗球蛋白测试和一些卡片测试.
在所有测试试验中,MagroEx有效地减轻了干扰.

结论:

抗CD47药物需要免疫血液学方面的意识和适应.
在接受抗CD47治疗的患者中,抗原掩护策略对于安全的血液产品管理至关重要.
继续开发抗CD47疗法需要强大的诊断协议.

关键词:

这是MagroEx.抗原掩饰是一种抗原掩饰.抗CD47抗体干扰的干扰间接抗球蛋白试验是一种间接的抗球蛋白试验.在输血前进行血液检测.

更多相关视频

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

相关概念视频

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Blood Typing

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...

Blood Transfusion

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

Rh Blood Group

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.